Vera Therapeutics

Vera Therapeutics VERA Stock

$26.97   -4.021356%
Add to favorites
Market Cap
$1.95B
LOW - HIGH [24H]
$26.86 - $28.17
VOLUME [24H]
$1.00M
P/E Ratio
0
Earnings per share
-$5.90
ISIN
US92337R1014
Price   Prediction

Vera Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Vera Therapeutics (VERA) stock price today is 26.97 USD on Tech Market Middle (-4.02% on the day). Updated .

Vera Therapeutics VERA Financial and Trading Overview

Vera Therapeutics stock price 26.97 USD
Previous Close 28.1 USD
Open 27.97 USD
Bid 22.14 USD x 100
Ask 38.91 USD x 200
Day's Range 26.86 - 28.17 USD
52 Week Range 26.38 - 56.05 USD
Volume 1M USD
Avg. Volume 1.99M USD
Market Cap 1.95B USD
Beta (5Y Monthly) 1.186
PE Ratio (TTM) N/A
EPS (TTM) -5.9 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 71.36 USD

VERA Valuation Measures

Enterprise Value 1.64B USD
Trailing P/E N/A
Forward P/E -6.888009
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 189.73413
Price/Book (mrq) 5.8515944
Enterprise Value/Revenue 159.978
Enterprise Value/EBITDA -3.857

Trading Information

Vera Therapeutics Stock Price History

Beta (5Y Monthly) 1.186
52-Week Change -4.61%
S&P500 52-Week Change 13.32%
52 Week High 56.05 USD
52 Week Low 26.38 USD
50-Day Moving Average 31.11 USD
200-Day Moving Average 36.14 USD

VERA Share Statistics

Avg. Volume (3 month) 1.99M USD
Avg. Daily Volume (10-Days) 1.61M USD
Shares Outstanding 72.3M
Float 52.62M
Short Ratio 7.14
% Held by Insiders 1.58%
% Held by Institutions 117.50%
Shares Short 12.14M
Short % of Float 19.10%
Short % of Shares Outstanding 16.79%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -4160.065%
Gross Margin 67.92%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -54.35%
Return on Equity (ttm) -113.46%

Income Statement

Revenue (ttm) 10.28M USD
Revenue Per Share (ttm) 0.15 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 6.98M USD
EBITDA -426300000 USD
Net Income Avi to Common (ttm) -415312992 USD
Diluted EPS (ttm) -5.9
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 384.04M USD
Total Cash Per Share (mrq) 5.31 USD
Total Debt (mrq) 76.79M USD
Total Debt/Equity (mrq) 23.05 USD
Current Ratio (mrq) 7.912
Book Value Per Share (mrq) 4.609

Cash Flow Statement

Operating Cash Flow (ttm) -375923008 USD
Levered Free Cash Flow (ttm) -244618256 USD

Profile of Vera Therapeutics

Country United States
State CA
City Brisbane
Address 2000 Sierra Point Parkway
ZIP 94005
Phone 650 770 0077
Website https://veratx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 362

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Q&A For Vera Therapeutics Stock

What is a current VERA stock price?

Vera Therapeutics VERA stock price today per share is 26.97 USD.

How to purchase Vera Therapeutics stock?

You can buy VERA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vera Therapeutics?

The stock symbol or ticker of Vera Therapeutics is VERA.

Which industry does the Vera Therapeutics company belong to?

The Vera Therapeutics industry is Biotechnology.

How many shares does Vera Therapeutics have in circulation?

The max supply of Vera Therapeutics shares is 72.3M.

What is Vera Therapeutics Price to Earnings Ratio (PE Ratio)?

Vera Therapeutics PE Ratio is now.

What was Vera Therapeutics earnings per share over the trailing 12 months (TTM)?

Vera Therapeutics EPS is -5.9 USD over the trailing 12 months.

Which sector does the Vera Therapeutics company belong to?

The Vera Therapeutics sector is Healthcare.

Vera Therapeutics VERA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24509.76 USD —
-2.49
8.22B USD — 24460.28 USD — 24882.04 USD — — 8.22B USD —
us US Tech Global Market Composite NQGM US 1868.76 USD —
-3.56
— — 1866.47 USD — 1913 USD — — — —
us US Tech Health Care IXHC US 1342.75 USD —
-1.87
— — 1340.49 USD — 1374 USD — — — —
$2.2T
Total marketcap
$78.17B
Total volume
BTC 59.24%   •   ETH 10.07%
Dominance
Select currency